Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
The massive wildfire in the Aude’s Corbières massif, has now been fully extinguished after three weeks. ...
Read More
It’s been reported that Uber plans to launch high-speed trains between London, Paris, Lille, and Brussels by 2029, partnering with Gemini Trains. ...
Read More
Éric Ciotti has officially announced his candidacy for mayor of Nice in the March 2026 municipal elections, challenging current mayor Christian Estros...
Read More
As 12 million students return to class in France on the 1st of September, several key changes are being introduced. These include mandatory sex educat...
Read More
A stormy and rainy episode is expected tomorrow in the Alpes-Maritimes and Var, with heavy rainfall possibly reaching 100mm along the coast....
Read More
